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Abstract
Purpose—Proton magnetic resonance spectroscopic imaging (MRSI) is a non-invasive modality
capable of generating volumetric maps of in vivo tissue metabolism without the need for ionizing
radiation or injected contrast agent. MRSI has been shown to be a viable imaging modality for
studying several neuropathologies. However, a key hurdle in the routine clinical adoption of MRSI
is the presence of spectral artifacts that can arise from a number of sources, possibly leading to
false information.
Methods—A deep learning model was developed that was capable of identifying and filtering
out poor quality spectra. The core of the model used a tiled convolutional neural network (CNN)
that analyzed frequency-domain spectra to detect artifacts.
Results—When compared to a panel of MRS experts, our CNN achieved high sensitivity and
specificity with an area under the curve of 0.95. A visualization scheme was implemented to better
understand how the CNN made its judgement on single-voxel or multi-voxel MRSI, and the CNN
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was embedded into a pipeline capable of producing whole-brain spectroscopic MRI volumes in
real-time.
Conclusion—The fully-automated method for assessment of spectral quality provides a valuable
tool to support clinical MRSI or spectroscopic MRI studies for use in fields such as adaptive
radiation therapy planning.
Keywords
MR spectroscopic imaging; spectroscopic MRI; machine learning; deep learning
Introduction
Proton magnetic resonance spectroscopy imaging (MRSI) is a quantitative imaging modality
that measures endogenous metabolite concentrations in vivo (1,2). Recent advances in MRSI
protocols, such as the development of the 3D echo-planar spectroscopic imaging (EPSI)
sequence, and improved post-processing methods have enabled whole-brain acquisition with
higher spatial resolutions, thereby improving utility for diagnostic and potentially
radiotherapy treatment planning applications (3–6). Three metabolites of key importance in
the evaluation of patients with glioblastoma, specifically choline (Cho), N-acetylaspartate
(NAA), and the Cho/NAA ratio. The Cho/NAA ratio is widely used for depiction of tumor
volumes and infiltration due to increased contrast as a result of the opposite changes of these
metabolites in the tumor (3). A key challenge to the analysis and interpretation of tumor
volume based on EPSI data is the presence of artifacts due to poor spectral quality (7).
Artifacts arise from magnetic field inhomogeneities, subject movement, or improper water
and lipid suppression, yielding reduced peak signal-to-noise ratios and distorted and
broadened line shapes that lead to difficulties in quantification of the metabolite peaks (7,8).
Visually, artifacts may appear as foci of hyper- or hypo-intense signal (Fig. 1), which can
lead to false interpretation. For treatment planning purposes, it is especially important to
obtain accurate volumetry of target pathology. Currently, confirmation of true metabolic
abnormality requires manual review of spectra by experts. However, with several thousand
spectra in an EPSI data set, manual review of whole-brain spectroscopy volumes is
impractical. To adopt whole-brain EPSI data into the clinical workflow, it is therefore
necessary to develop automated methods for assessment of spectral quality.
Several approaches have been developed to filter poor quality spectra from MRSI datasets,
including exclusion criteria based on peak linewidths (5), reliability testing (9), Cramer-Rao
bounds (10), and machine-learning techniques such as random forest classifiers (11,12). In
each of these algorithms, the classification of spectral quality is based on a collection of
“engineered” features as input; these features are categorical or ordinal vectors that seek to
summarize the information encoded in each spectrum. Some features are derived directly
from the raw data, such as the magnitude of each point in the spectrum or statistical metrics
of variability (e.g. kurtosis, skewness) (12), or derived from analysis of spectral fitting, such
as singlet linewidths and Cramer-Rao bounds. Common to all these approaches is that the
definition of features is required prior to performing any analysis. Thus, these features
capture criteria that MRS experts explicitly believe are important to spectral quality, and
machine learning algorithms built using these engineered features have shown promise as
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spectral quality filters (11–13). In contrast to systems that model expert beliefs explicitly,
deep learning broadly defines a category of machine learning algorithms that can learn
underlying features from raw data without the need for any a priori definition of such
features, and have been able to shatter benchmarks in natural language processing, medical
image segmentation, survival analysis, and identification of pathology in medical images
(14–18). Deep convolutional neural networks (CNNs) in particular are well suited to
analyzing waveforms similar to raw spectra (19,20), and have only recently been applied in
the context of MR spectroscopy (21). CNNs consist of sequential layers of convolution,
downsampling, and logistic regression that ultimately learn the underlying features of the
data that lead to a desired endpoint, in this case whether or not a spectrum is suitable for
analysis. Training a CNN involves updating the coefficients of the convolutional layers to
reach the endpoint. However, designing the architecture of a CNN – e.g. the number of
layers and the size of the convolution kernels – often relies on trial and error. A new
framework to determine optimal architecture parameters is known as Bayesian optimization,
which performs non-linear optimization without the need for defined derivatives (22).
In this work, a CNN was developed to learn whether or not a spectrum has sufficient quality
to be used for clinical assessment. A state-of-the-art Bayesian optimization technique was
used to automatically tune the network architecture and train the network on data from
patients with glioblastoma. A framework is provided that enables users to visualize the
rationale behind the CNN’s classification of individual spectra. Finally, a software pipeline
was implemented that enables real-time filtering of whole-brain EPSI data.
Methods
Image Acquisition and Processing
EPSI data were available from a database of patients with glioblastoma previously enrolled
in a phase II clinical trial (23) who received post-surgical scans. All scans were conducted in
a 3T MRI scanner with a 32-channel head coil (Siemens Medical) and were obtained
following surgical resection but prior to the start of radiation therapy and chemotherapy.
Anatomic volumes obtained used a T1-weighted (T1w) magnetization-prepared rapid
gradient echo pulse sequence (TR = 1900 ms, TE = 3.52 ms, 256 × 256 matrix, flip angle
(FA) = 9°). A whole-brain 3D EPSI sequence (TR = 1551 ms, TE = 17.6 ms, FA = 71°, final
matrix size of 64 × 64 × 32) was obtained during the same scanning session, as previously
reported (3). Both sequences were obtained at a +15 degree tilt in the sagittal plane from the
anterior commissure-posterior commissure line in order to capture the entire cerebrum while
minimizing acquisition in the clivus, sinuses, and retro-orbital fat. An oblique saturation
band was placed in the sagittal plane from the optic chiasm to the cerebellum to suppress
signal from those regions. Image reconstruction and formation of metabolite images were
carried out using the Metabolite Imaging and Data Analysis System (MIDAS) package
(5,6). Briefly, this processing includes spatial reconstruction, frequency alignment, B0 field
correction, co-registration of the T1w and EPSI volumes, registration of the T1w volume to
an anatomic atlas, lipid suppression, spectral fitting, and normalization with internal water
signal to produce relative concentrations of metabolites. Additionally, pre-filtering of data
using algorithms built into MIDAS was applied to all data to replicate the workflow
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currently used in clinical studies. First, a mask based on an anatomic atlas was applied to
exclude voxels outside of the brain, which drastically reduces the number of voxels to be
analyzed. Voxels with a water linewidth > 18 Hz, as calculated from T2 decay, were
removed prior to spectral fitting to save computation time. After fitting, voxels with a
metabolite linewidth > 18 Hz were also removed; this step served as an initial filter to
remove spectra known to be of poor quality prior to visual review. A representative volume
contained 10,298 voxels after filtering, however, since the data is also interpolated and
smoothed in each dimension during reconstruction it is estimated that approximately 1,280
independent spectra remain within the brain volume. Spectra were then randomly sampled
from a grid with a skip factor of 2, including both regions of tumor and healthy tissue, and
exported for analysis. A total of 8,894 spectra collected from 9 patients with glioblastoma
were collected.
Data Labeling and Consensus
A custom web platform for multi-rater annotation of spectral quality was developed and
used to label the exported spectra for training and testing the artifact detection network.
Online Spectroscopic Classification and Review (OSCAR) was written in PHP – a language
for server-side scripting of webpages – and enables multiple MRS experts to visualize and
review spectra, as seen in Figure 2. Each expert is presented with a random subset of spectra
and shown the chemical-shift spectrum along with a cross-haired T1-weighted MR image
depicting the spectrum’s anatomic location. The user classifies the spectrum’s quality as
“Good”, “Acceptable”, or “Poor”, based on their expert opinion.
Each spectrum was presented to three randomly chosen users from a pool of experts (authors
AAM, JSC, BJS, HP, GV, PBB, and HS) so that an expert consensus could be measured; a
total of 8,894 spectra were classified in triplicate. Consensus was based on a majority vote
decision rule; if all three voted differently or if there was a large discrepancy in votes (e.g. 2
“Good” and 1 “Poor” or vice versa), the spectrum was discarded. Table 1 includes the
results of labeling and consensus; a total of 427 spectra (4.8%) were discarded due to large
discrepancy amongst experts. The consensus labels of “Good” and “Acceptable” were
merged together into a singular “Good” class, yielding a class proportion of 72% “Good”
and 28% “Poor”. The final set of 8,467 spectra were then randomly split 80:10:10 for
training, validation, and testing subsets, with class proportions maintained.
Network Architecture
A CNN for spectral quality was developed using the TensorFlow (Google, Inc.) framework
on a Windows workstation with two Titan × graphical processing units (GPUs). GPUs are
highly optimized for parallel computations and enable rapid development of neural
networks. A high-level overview schematic of the CNN is displayed in Figure 3a. It takes
the 512-point real component of a spectrum as input. First, the spectrum is normalized to
values between 0.0 and 1.0; for this step, a histogram of amplitudes of all spectra in the
training data set was computed, and the 1st and 99th percentile values were used as the
normalizing bounds. Using these bounds, all spectra are normalized to the same scale. The
normalized spectrum is then split into six regions, called “tiles”. Three of these tiles were
based on the known location of resonance peaks for the three largest metabolite peaks
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present: Cho (3.2 ppm), Cr (3.0 ppm), and NAA (2.0 ppm). Given the short TE that the data
were acquired at, these three tiles are primarily composted of a Lorentzian-Gaussian singlet
as opposed to the slowly-changing spectral baseline and smaller overlaid macromolecule
singlets found in other tiles (8). Since these tiles have different shapes, the tiled architecture
effectively enables six parallel networks to be trained synchronously. Each tile is passed
through a series of convolutional and max-pooling layers. Layers 1 and 2 each perform 32
convolutions on the data, and layers 3–7 each perform 64 convolutions. Since CNNs operate
best on low-amplitude data, outputs from each convolution are passed through a parametric
rectified linear unit (PReLU), which restricts output range (24). Max-pooling downsamples
the output of each convolution by a factor of two, reducing the size of the data going into the
next layer. After these 7 layers, outputs from each of the six tiles are concatenated together
and passed through two fully-connected layers of 128 nodes. Finally, logistic regression and
softmax (25) operations are performed to yield a single scalar output within the range [0.0,
1.0]. The CNN is trained so that this output is the probability of the input spectrum being
classified as “Good”.
Training the CNN involves optimizing the coefficients of all the convolution kernels and
fully-connected nodes so that the output matches the consensus of the training data
generated in OSCAR. If the consensus output was “Good”, the spectrum is given a class
label of 1, and if the consensus output was “Poor”, the spectrum is given a class label of 0.
The cost function to be minimized by a first-order optimizer is defined as the cross-entropy
error of the class label and the output probability of the CNN (26). Spectra are passed in
batches of 250 spectra through the network and the cost function is computed; gradient
backpropagation then adjusts the network coefficients. For each batch, spectral from the
training data set are randomly sampled without replacement; an epoch is defined as one full
pass-through of the training set. After each epoch, a receiver-operator characteristic (ROC)
curve is computed on the validation (n=850) sets, and the area under the curve (AUC) is
reported. Training continued through many epochs until the AUC of the validation set
converges.
Bayesian Optimization
CNN architecture hyperparameters, e.g. the number of layers in the CNN and the size of the
convolution kernels, can have a large impact on performance. These hyperparameters cannot
be defined by linear mathematical functions and therefore do not have explicit derivatives to
be used for gradient backpropagation. Because of this, they are outside the scope of neural
network training and are often defined by manual trial and error, which can be both time-
consuming and highly subjective. Bayesian optimization is a statistical technique that
models the performance of an algorithm using Gaussian processes and iteratively seeks to
optimize performance over the space of possible algorithm designs (22,27,28). CNNs can be
treated as a complex mathematical function with some unknown underlying statistical
model. Bayesian optimization assumes a series of Gaussian distributions can reproduce the
underlying model and uses those to indirectly optimize the CNN; this technique has
previously been successfully applied to tune architecture hyperparameters (18,22). A
Bayesian optimization approach using the Spearmint framework is used in this work to tune
the size of the convolution kernels and the dropout fraction of the fully connected layers
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(22). The variable to be minimized for Bayesian optimization is defined as the converged
AUC of the validation data set as described in the previous section (Fig. 3b).
Gradient-weighted Class Activation Mapping
While deep learning algorithms such as CNNs extract predictive features from input data,
these features do not have any semantic meaning, and it is not readily apparent how to
interpret them in a manner similar to feature ranking by standard statistical techniques. A
recent method known as gradient-weighted class activation mapping (GradCAM) attempts
to visualize which components of a specific input contribute to that input’s classification.
GradCAM performs a gradient backpropagation from the output score to the final layer of
convolution, which contains the highest level features detected by the network (29). These
can then be visualized as heat maps over the original input, highlighting which components
contributed most to the CNN’s decision. While this cannot be generalized to all input, it
enables insight into what the network is doing. We implemented GradCAM for spectral data
in TensorFlow.
Results
Training and Validation
The CNN was trained over multiple epochs (complete passes through the training set) until
the validation AUC achieved its peak value, an indication that additional training would
result in overfitting. The Bayesian optimization framework was programmed to maximize
the peak validation AUC, and this along with a 2×2 contingency table (30) was reported for
each parameter set. The final tuned parameters reported by Spearmint were the CNN
learning rate and convolution kernel size. After Bayesian optimization was complete, the
unused test set (n=850 spectra) was run through inference and probabilities were compared
with reviewer labels to generate the final ROC curve shown in Figure 4a, with an AUC of
0.95.
To compare the classifications of the CNN against each human expert’s classifications, an
inter-rater agreement analysis was performed. A dissimilarity matrix, representing the
percent disagreement between each pair of observers was calculated (Figure 4b).
Multidimensional scaling a technique that transforms these pairwise distances into a two-
dimensional map to further visualize the relative agreement between pairs of raters, was
performed (Figure 4c) for the seven human raters (H1–H7) and the CNN on the full data set.
In a multidimensional scaling plot, points that are closer together represent higher agreement
between the two raters’ decision on spectral quality. The geometric center of the human
raters is also displayed on the plot. After training and tuning of the CNN were complete, it
was run on the 427 spectra which the experts disagreed on, using a threshold of 0.7 on the
CNN’s output probability for classification. A summary of the results is presented in
Supporting Table S2; of note, the majority of these spectra were classified by the CNN as
having good quality.
To evaluate the relative performance of the CNN against traditional machine learning with
engineered features, a random forest was generated using the same input and ground truth
data using the Statistics and Machine Learning Toolbox in MATLAB R2016b (The
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MathWorks, Inc.). Twenty features generated by MIDAS during the fitting process were
used (Supporting Table S1), and the model achieved an AUC of 0.948 after optimizing
random forest parameters. The ranking of features is shown in Supporting Figure S1.
Gradient-weighted Class Activation Mapping
Representative spectra are shown in Figures 5–6 with overlaid heat maps generated by
GradCAM, revealing regions of the spectrum that contributed most to the CNN’s
classification decision. In Figure 5, four representative spectra are shown, each with
different causes leading to poor quality per the opinion of two of the MRS experts.
GradCAM highlights the regions of spectrum that correspond to those causes. To assess how
the CNN makes a classification decision on good quality spectrum, an idealized “Good”
spectrum is generated by taking the average of the amplitude all spectra classified as “Good”
by the five readers (Fig. 6), which increases the signal-to-noise ratio and reduces baseline
variations. When GradCAM is run on this idealized spectrum, the heat map reveals that it is
the regions outside of the metabolite resonance frequencies, e.g. the region of lipid and
water signal, that contribute most to the CNN’s classification.
Whole-brain Pipeline
A pipeline was developed for filtering spectral artifacts on whole-brain volumes. Briefly, all
spectra were exported to a binary format able to be read by TensorFlow and tagged with
their voxel locations for reconstruction. The trained CNN was then loaded and inference is
performed on all voxels in a whole-brain volume; a probability of “Good” quality is
exported and reconstructed into a 3D volume representing probability. A threshold on this
probability can then be selected and applied to all metabolite voxels, eliminating those
below it from the map; a threshold of 0.70 was selected for the whole-brain images depicted
here. Figure 7 shows a sample pre-radiation therapy Cho/NAA volume from a patient with a
newly diagnosed left frontal glioblastoma following surgical resection of the tumor. Voxels
with broad linewidths were already removed during data processing in MIDAS with an
initial filter based on water and metabolite linewidths. Cho/NAA elevation is observed
posterior and medial to the surgical cavity, suggesting residual tumor. Additionally, in the
unfiltered Cho/NAA maps, there appears to be residual tumor in the anterior tip of the left
frontal lobe. However, inspection of the spectra in these voxels reveals that the spectra are of
insufficient quality to make an accurate assessment of pathology. Examples of spectra from
eliminated voxels are shown, taken from regions of cellular necrosis, low signal-to-noise-
ratio, and insufficient lipid suppression. This whole-brain pipeline is implemented using the
Python version of TensorFlow, and is portable across multiple computer operating systems
and hardware, including low and mid-tier GPUs. On a system with a low-end GPU (Nvidia
GTX 1050 Ti), processing takes less than 2 minutes. Removing the GPU and running the
pipeline only on a multicore CPU (Intel i7-6900K, 8 cores) also takes 2 minutes to process a
whole-brain volume.
Discussion
The CNN-based spectral quality filter developed in this study was found to perform well for
detection of inadequate quality spectra, as labeled by a consensus decision of MRS experts,
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with an AUC of 0.951, indicating the network has been tuned for both high sensitivity and
specificity. Furthermore, the network is wrapped into a framework that enables rapid
deployment of the filter into the clinical research workflow, and can be applied in under 2
minutes to high resolution EPSI data with whole brain coverage. The accuracy achieved is
similar to that reported in previous studies using machine learning for MR spectral quality
analysis, such as those utilizing random forests with engineered spectral features (11,13,31).
It is difficult to compare results across studies, due to variation in study design: how data
was collected, the biases of the raters generating ground truth, and which parameters were
chosen as features. To enable direct comparison of performance between the CNN and a
machine learning algorithm with engineered features, a random forest was built on the same
training and testing data collected in OSCAR. While the CNN demonstrates slightly better
performance, a key advantage of the deep learning approach over the random forest is that
does not require any engineered features generated by spectral fitting. As a result, it is
independent of specific features derived from fitting algorithms and is compatible with a
broader set of pipelines and workflows. Of note, the spectra in this work do undergo
preliminary linewidth filtering in MIDAS prior to being processed by the CNN, which
reduced the spectra needed to undergo spectral fitting and excluded spectra with broadened
metabolite linewidths known to be of poor quality. This decision was made to use the status
quo of spectral quality filtering as a starting point and to develop an algorithm that makes
additional improvements to it. In future workflows, applying filtering prior to spectral fitting
could reduce the computation time for spectral fitting, a time-intensive process, especially
since poor quality spectra may require considerably more processing during fitting, due to
their abnormal shapes.
While artifacts can occur anywhere in the tissue parenchyma, they are more common at air/
tissue boundaries due to local magnetic field inhomogeneities and near the periphery due to
partial volume effects with strong lipid signals in scalp. It is well known that magnetic field
inhomogeneity occurs in the inferior frontal lobe, anterior temporal lobe, and superior to the
mastoid air spaces due to magnetic susceptibility differences between air and tissue. In
patients who have undergone surgery, additional artifacts in EPSI data can occur due to
magnetic susceptibility from craniotomy staples and possibly from hemorrhage. In this first
iteration of the spectral quality CNN, this information is not taken into account insofar as it
is not encoded into the spectrum itself. Future work could include the registration of
metabolite or metabolite ratio (e.g. Cho/NAA) maps onto a common anatomical atlas and
input the anatomical location of each spectrum into the CNN, either in terms of absolute
location or relative distance from the nearest tissue boundary (i.e. ventricle, dura).
Additionally, a label collection scheme was implemented to take into account the inter-
reader variability of spectral evaluation by multiple MRS experts. This is a key step in
improving the generalizability of our algorithm, since each reader is independently looking
for particular spectral patterns based on his or her own expertise. As shown in Table 1, there
often was disagreement amongst the experts, including approximately 5% of data with
complete discordance. As such, the performance of classifiers reflects subjectivity of the
human raters that define the ground truth. Multi-center and multi-expert analyses have
previously been conducted for brain tumor classification, and have shown the necessity of
such data in establishing quality control norms (32). Inter-rater reliability was assessed by
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computing the disagreement on spectra for every pair of raters, including the seven MRS
experts and the CNN. The multidimensional scaling plot in Figure 4c shows that the distance
between the CNN and any of the human raters is not more extreme than the distance
between any pair of human reviewers, suggesting that the CNN algorithm agrees with
humans about as well as humans agree with each other. Furthermore, the CNN is close to
the geometric center of the human raters, which is in accordance with the methodology used
to train the CNN; the spatial distance can be attributed to consensus scheme used during data
labeling, which deviates from the mean of the three user labels. The OSCAR platform
designed for this work is readily available to be used for future experiments requiring multi-
user input. For this work, MRS experts were asked to judge the quality of spectra only based
on the metabolite spectrum and its location in a 2D slice. In reality, experts use additional
information when assessing MRS data: the strength of the water signal; comparison of the
fitted and unfitted spectra; and the pathology of the spectrum’s location, e.g. from tumor or
healthy tissue. These will be added to OSCAR to supplement data collected in future
studies.
Another challenge in developing algorithms for spectral quality filtering is the low
percentage of poor quality voxels present in a whole-brain volume compared to good quality
voxels, which yields an imbalance in class proportions and consequently can hinder
algorithm performance (13). In the dataset collected in this work, 72% of spectra were of
good quality and 28% were of poor quality, which is similar to proportions (65 – 84%
acceptable spectra) observed in other works (11,13,31). To assess whether balanced class
proportions would affect CNN performance, a random minority oversampling scheme was
implemented, wherein data from the minority class (poor spectra) are randomly sampled
multiple times to artificially increase the number of samples. A new CNN was trained using
the same network architecture on this oversampled dataset, with 5991 good quality and 5991
poor quality, and tuned using Bayesian optimization as described in Methods. The resulting
AUC was slightly improved compared to the original CNN, at 0.960 (Supporting Figure S2).
This suggests that the CNN is robust to the class imbalance of the ground truth dataset, but
that a more balanced data set could potentially improve outcomes. Of note, the imbalance is
relatively small, being only a factor of ~2.6, whereas in other domains where deep learning
has been applied the imbalance can be several orders of magnitude (33).
Based on the results of GradCAM, the user can glean some insight into how the network
arrives at a decision. An ideal “good” spectrum is simulated by averaging all spectra labeled
as “Good”, creating a high signal-to-noise ratio spectrum with all peaks visible (Fig. 6). The
GradCAM evaluation of this simulated spectrum suggests that the network appears to focus
on regions outside of the main metabolite peaks, specifically on unsuppressed lipids,
unsuppressed water, and the overall baseline waveform. Because all spectra evaluated by
spectroscopy experts were already passed through a linewidth filter, they were known to
have metabolite peaks with narrow linewidths and low Cramer-Rao bounds. As such, the
artifacts are arising from other aspects of the spectrum, and the CNN is focusing on these
other spectral features. GradCAM visualization also provides a benefit over traditional
machine learning methods, in that it can localize the band(s) of an individual spectrum that
explain a CNN classification result. In contrast, interpretation of random forests can only be
performed on a “population” level, explaining what features are critical in performing
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classification in the entire dataset, and cannot provide insights into the classification of
individual spectra.
In order to incorporate the spectral quality CNN into a clinical research workflow, a Python
application programming interface to query the CNN from other software was developed.
The CNN model can perform inference of an entire whole-brain volume on an affordable
GPU or on a multicore CPU, and has been deployed to an in-house spectroscopic MRI web
app so that it can be easily applied to clinical studies. While training a CNN is
computationally intensive and requires powerful GPU hardware, applying the CNN is much
less intensive and can be done on commodity hardware, either a low-end GPU or a high-end
CPU like the configurations described in the Results section.
Conclusion
A deep learning algorithm was developed to automatically detect poor quality spectra in
whole-brain EPSI data that otherwise would lead to incorrect classification of voxel
pathology. This approach achieved high accuracy when compared to a consensus decision
from a panel of MRS experts, and achieved comparable accuracy to classifiers based on
engineered features developed in this work and by others. The key advantage of the CNN
developed here is its ability to operate directly on spectra, enabling quality filtering
independent of the fitting algorithm and requiring no engineered features. The CNN
identifies poor quality spectra and artifacts with a high degree of sensitivity and specificity,
and has been integrated into a whole-brain spectroscopy processing pipeline. Frameworks
such as convolutional neural networks are well suited to the high dimensionality of EPSI
data and can extract information that contributes to spectra quality from the spectral
waveform beyond what is extracted using engineered features. To provide feedback to
spectroscopy experts, we also implemented a GradCAM-based visualization approach that
localizes artifacts in spectra, and that can provide a rationale for classification decisions to
the user on individual spectra. In this first iteration, the CNN was trained to identify spectral
quality based only on spectral waveforms with no regard to other factors that play a role in
experts’ assessments of quality, such as location of the voxel or any known pathologies in
the brain. Future work will focus on collecting training data and developing a CNN that can
take these into account, by incorporating an anatomic atlas and assessing local pathology.
Ultimately, the implementation of an automated spectral quality filter will mitigate errors
due to incorrect classification of pathology, and assist in pushing whole brain 3D EPSI
technology into clinical decision-making.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Artifacts in MRSI arise due to several causes and can lead to false interpretation of
pathology. (A) Healthy tissue shows a relatively low choline to N-acetylaspartate ratio (Cho/
NAA), whereas (B) tumor shows an elevated ratio, appearing as hyperintense on a
Cho/NAA map. Artifacts can arise in tissue boundaries and in areas with poor lipid or water
suppression, and can result in either (C) hyperintense lesions or (D) dropout of signal.
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Figure 2.
To collect ground truth data for machine learning classifiers based on spectral quality, we
developed a web-based interface for MR experts to use.
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Figure 3.
(a) A high-level overview of the convolutional neural network for spectral quality analysis.
Input spectra are split into six tiles and passed through a series of convolution (*) and max-
pooling (MP) layers, then concatenated and passed through fully connected layers to
generate a scalar output of spectral quality. (b) Bayesian optimization is used to iteratively
optimize architecture hyperparameters.
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Figure 4.
(a) An unused test data set (n=850 spectra), with class proportions matching that of the full
data set, was run through the CNN; comparing the output probabilities to ground truth
resulted in a receiver-operator characteristic curve with an AUC of 0.951. The (b)
dissimilarity heatmap and (c) a multidimensional scaling plot comparing sets of pairwise
inter-rater agreement show that the CNN’s similarity with any given human rater is within
the ranges of inter-human rater similarity.
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Figure 5.
Four spectra representative of the various phenomena that lead to artifacts were analyzed
using GradCAM, a technique which produces a heat map of which portions of a specific
input spectrum contributed most to the CNN’s final decision. The results show that the CNN
is focusing on appropriate regions for each of these scenarios. Of note, when there is low
signal-to-noise ratio due to partial volume effects at a tissue boundary (bottom left), nearly
the entire spectrum is detected.
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Figure 6.
An idealized “Good” spectrum, created by averaging all spectra classified as “Good,” shows
that the CNN focuses most on the regions outside of the metabolic peaks for decision
making.
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Figure 7.
The spectral quality CNN can be applied to whole-brain volumes in real-time to assist
clinicians in making accurate decisions based on MRS, such as the Cho/NAA volume. In a
pre-treatment assessment, the CNN filters out voxels in the necrotic tumor core, anterior
frontal lobe, and multiple voxels in the occipital lobe which have poor quality.
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